Skip to main content

Quest to Develop Diagnostics Using SomaLogic Aptamer Tech; Invests $15M in Firm

NEW YORK, May 9 (GenomeWeb News) - Quest Diagnostics will develop new diagnostic tests based on SomaLogic's proprietary aptamer array platform, the companies said last week.

 

Terms of the deal call for Quest to make a $15 million equity investment in SomaLogic. Additional terms of the arrangement were not disclosed. Timetables for test development were not provided.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.